Opioid-use disorder among patients on long-term opioid therapy: impact of final DSM-5 diagnostic criteria on prevalence and correlates

Previously, we estimated the prevalence and risk factors for prescription opioid-use disorder among outpatients on opioid therapy using the Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 and DSM-4 criteria. However, at the time, the DSM-5 criteria were not finalized. In the current st...

Full description

Saved in:
Bibliographic Details
Published in:Substance abuse and rehabilitation 2015-01, Vol.6 (default), p.83-91
Main Authors: Boscarino, Joseph A, Hoffman, Stuart N, Han, John J
Format: Article
Language:English
Subjects:
Alcohol
Care and treatment
Classification
Clinics
Interviews
Medical diagnosis
Medical research
Mental depression
Mental disorders
Narcotic abuse
Narcotics
Nicotine
Original Research
Pain
Patients
Post traumatic stress disorder
Prescription drug abuse
Prescription drugs
Risk factors
Standard deviation
Substance use disorder
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Previously, we estimated the prevalence and risk factors for prescription opioid-use disorder among outpatients on opioid therapy using the Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 and DSM-4 criteria. However, at the time, the DSM-5 criteria were not finalized. In the current study, we analyzed these data using the final DSM-5 criteria and compared these results. Using electronic records from a large US health care system, we identified outpatients receiving five or more prescription orders for opioid therapy in the past 12 months for noncancer pain (mean prescription orders =10.72; standard deviation =4.96). In 2008, we completed diagnostic interviews with 705 of these patients using the DSM-4 criteria. In the current study, we reassessed these results using the final DSM-5 criteria. The lifetime prevalence of DSM-5 opioid-use disorders using the final DSM-5 criteria was 58.7% for no or few symptoms (
ISSN:1179-8467
1179-8467
DOI:10.2147/sar.s85667